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On October 21, 1982 , in Brussels at BCR headquarter , the pa rtleipants 
agreed to work on impravement of the quality of PCB analysis . 
Results of a first excercise \o~ere discussed in Pitlochry (UK) on 22-23 
June 1983 . Based upon the report of the first exercise (Re por t 83 . 44 -
BCR- ringtest of individual chlorobiphenyls (1/1983 ) - Summary of 
results, dated 1983- 05- 26 ) and the minutes of the meeting i n Pitlochry 
a second interlaboratory test was organized by the State Institute for 
Quality Control of i\gricultural Products (RIKILT), Hageningen , The 
Netherlands. It Has decided to keep attention to the fol lowing points: 
a) optimization of the gaschromatographic system 
b) comparison of splitless injection and on- column injection 
c ) analysis of "unkno"m" standard solution chlorobiphenyls. 
Through on column i n jee ti on could be of grea t importance, it \f7as left 
to the partleipants initiative to prove this statement by carrying out 
a nd splitless- and on- column injection using tlte same GC column i n the 
same equipment . 
2. Partleipants 
A complete list of the 15 participating laboratorles is given i n Annex 1. 
Results only from 14 laboratorles are included in the statistica! ana-
lysis. 
3 . Haterials 
Ampuls for the ringtest ,.,ere prepared by RIKILT and send to the par-
tielpants \oTith the folioHing information: All ampuls cocled A- E contain 
solutions in iso- octa ne . Volume nbout 5 ml. Hhen necess~ry make dilu-
tions only i n iso-octane . 
A Test salution for optimizing purposes containing the 
PCB- compounds 153 and 138, each 0,1 pg/ml and the inte rnal s t an-
dards 1,2,3,4-tetrachloronaphtalene (TCN) 0,1 pg/ml and hexabro-
mobenzene (HBB) 0,4 pg/ml. 
B- C: Test mixture for linearity test containing the PCB- compounds 153 
and 138, each 0,5 pg/ml (ampul B). Internal standard solution of 
TCN, also 0,5 pg/ml (ampul C). 
D Standard s olution \o~ith the PCB-compounds 28 , 52 , 101, 118, 153, 
138 and 180, each 0,1 pg/ml and the internal standard TCN 0 , 1 
pg/ml and HBB 0,4 pg/ml. 
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E Standard salution 1-1ith "unknoi.Jn" concentration of PCB compounds 
and known concentrations of internal standards . The concentration 
of the internal standards is equal to the concentrations in ampul 
D. 
The receipt I.Jas confirmed by 1o1ay of a receipt/ confirmation letter to 
the RIKILT (Annex 2). 
4 . Optimization procedure 
4 . 1 Optimization of gaschromatographic conditions 
Adjust the GC settings as advised by the rnanufacturer of the capillary 
column and norrnally used in your PCB-analysis . 
Linear gas velocity (u) at 220°C in the capillary (0,2-0,3 mm) should 
be for nitrogen 10-15 cm/sec, for helium about 25 cm/sec and for hy-
drogen about 35 cm/sec. 
u length column cm/sec 
retention time of unretarded peak *) 
*) For practical purposes use for the unretarded peak the appearance 
of the solvent peak on the recorder. 
Do not use integrating systems for measuring peak height and area. 
4 . 2 Splitleas injection 
Inject in all experiments 1 ~1. Use for the experiments 4.2.1, 4.2.2 
and 4 . 2.3 a higher chart speed on the recorder (for example 6 cm/min) . 
4 . 2.1 Determination of the minimum closing time of ~1e splitter 
Use ampul A in an appropriate concentration. Nake 1-1hen necessary dilu-
tions ,.,i th iso-oe tane. Use the follo-ç,Ting temperature programmine: 
initial temperature 4 min 90°C - program rate 10°C/min - final tem-
rerature 220°C. 
Vary the closing time of the splitter in the range 0-3 min for at least 
three times, starting at 0,2 min until a maximum response (peak height 
x peak 1-1idth at half height in mm2) for PCB compound 153 is obtained 
(for example 0,2 min- 0,5 min- 1,0 min) . 
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Report the results for a) peak height, b) peak ~qid th at half height 
and c) peak area as a function of the chosen closing time of the 
splitter in the table in annex 3. 
(Peak area defined as the product of peak height and peak width at 
half height in mm2). 
Use for the next experiments the optimum closing time of the splitter. 
4.2.2 Determination of the optimum i nitial oven tempersture 
Use ampul A in an appropriate concentration. Nake ~qhen necessary dilu-
tions with iso-octane. 
Vary the initial tempersture in the range 70-130°C (for example 70 -
90 - 110- 130- •••••••• • ••••••• °C). 
Inject 1 ~1 of the testsolution. Start programming after 4 min with a 
program rate of l0°C/min, final tempersture 220°C. Of course the ini-
tia! time must be grester than the optimum closing time of the 
splitter. Calculate a) the resolution (R) between the PCB-compounds 
153 and 138, b) the ratio peak height/peak area for the PCB-compound 
153 and HBB and c) the peak symmetry for PCB-compound 153 . 
(Peak area defined as the product of peak height and peak width at 
half height in rrun2), 
Report the results in the upper part of annex 4 . 
R tr2 - tr1 
'~ 1 112 + H21/2 
tr1 = retention time of PCB-compound 153 (mm) 
tr2 retentien time of PCB-compound 138 (mm) 
H1/2= peak wiel th at half height (mm), 
peak symmetry (a/b)2 
a and b measured at 10% of peak height, perpendicular to this line, a 
at frontside of peak height and bat backside (see figure below). 
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increasing retention titne 
Use for the next experiment the optimum initial oven temperature of 
the capillary column at the optimum closing time of the splitter. 
4.2.3 Determinatlon of the optimum injector temperature 
Use ampul A i n an appropriate concentration. Nake '~hen necessary dilu-
tions with iso-octane. 
Determine the effect of the injector temperature, on a) the resolution 
of the PCB- compounds 153 and 138, b) the ratio peak height/peak area 
for the PCB-compound 153 and HBB and c) the peak symmetry for 
PCB-compound 153, in the range 180-240°C for at least three tem-
peratures. 
Program rate and final temperature equal to as described und er 4 . 2 . 2. 
Report the results in the lower part of annex 4. 
Uptill no\~ '"e did not ask you to anticipate to the behaviour of HBB. 
When you found in the optimization of the injector teroperature a dif-
ferent optimum for peak resolution of the PCB-compounds 153 and 138 as 
for the response of HBB, it is advisable to optimize the injector 
temperature for maximum HBB response, because we also '~ant a maximum 
response for higher chlorinated biphenyls. 
After doing so and especially when you find nmv a much higher injector 
temperature as used und er 4.2.2, it is advisable to repeat the opti-
mizing of the initia! temperature. 
Repoet in annex 5 the optimum gaschromatographic conditions that you 





4.3 On column injection (optional) 
A detailed methad of analysis for optimizing can not be given , because 
the on-column injection system differs between apparatus; also contra-
dictory procedures are reported in literature . 
The optimizing procedure is not optional 1o1hen in your apinion on-
column injection is superior to splitleas injection for PCB analysis. 
He ask you to report enough evidence to justify your conclusion. 
Use , to campare results of on-column injection and splitleas injec-
tion, the same capillary column and Hhen possible the same gaschroma-
tograph . 
Inject in all experiments 1 J-11. Use for the experiments a higher chart 
speed on the recorder (for example 6 cm/min). 
Consult for optimizing the on- column injection system the manual of 
the manufacture and adjust the GC settings as advised for the 
capillary column and norma1ly used in your PCB analysis. Keep in par-
ticular attention to the way of injection (slol•7 or quickly) and the 
back flush of the sample out of the capillary column. To avoid the 
back flush Carlo Erba uses, for example, a secondary cooling. 
4.3 . 1 Proposal for the determination of the optimum initial oven tem-
perature 
Use ampul A in an appropriate concentration. Make when necessary dilu-
tions with iso-octane. 
Vary the initial tempersture in the range 70-130°C (for example 70 -
90 - 110 - 130- •••••••••••• °C). 
Inject 1 )-11 of the test salution A. Start programming after 1 min with 
a program rate of 10°C/min, final temperature 220°C. 
Calculate the resolution (R) between the PCB-compounds 153 and 138, 
the ratio peak height/peak area for the PCB-compound 153 and for HBB 
and the peak symmetry only for PCB-compound 153. 
(Peak area defined as the product of peak height and peak width at 
half height in nuu2). 
Formulas see 4.2 . 2. 
Report the results in the upper part of annex 6 . 




4.3.2 Proposal for the determinatlon of the optimum starti.ng time for 
temperature programming 
Determine for at least three times in the range 0- 3 min the optimum 
starting time for temperature programming (for example 0,2 - 0,5 - 1,0 
min) . 
Inject 1 ~1 of the test solution A in an appropriate concentration. 
Calculate the resolution (R) betHeen t he PCB-compounds 153 and 138, 
the ratio peak height/peak area for the PCB-compound 153 and for HBB 
and the peak syn1owtry only for PCB-compound 153. 
(Peak area defined as the product of peak height and peak ~-1id th at 
half height in mm2). 
Report the results in the lower part of annex 6. 
Repot·t in annex 7 the optimized conditions of the on-column injection 
and the GC settings . 
4.4 Linearity test 
Hake dilutions from ampul B ~-1ith iso-octane to obtain at l east three 
different concentrations. Ratio bet~-1een maximum and minimum con-
centration should be at least a factor 5. 
Add to each of the three concentrations the same quantity of the 
internal standard (ampul C) , so that with one attenuation set ting of 
the equipment the response for all peaks of all three concentrat ions 
is within recorder scale. 
Of course the quantity you inject should be in the normal lineair 
working range for PCB- analysis on your equipment. 
Determine for PCB-compound 153 and the internal standard TCN the ratio 
peak area/injeeteel pg of the compound for the three concentrations in 
duplo. 
Report the results for splitless injection respectively on-column 
injection (optional) in annex 8. 
4. 5 Procedure for the interlaboratory test 
Inject 1 ~1 of the standard D in an appro priate concentration and 
inject four times 1 ~1 of the sample E in an appropriate concentration 
und er the optimized gaschromatographic conditions after dilution in 
the lineair range of your equipment. 
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Calculate the "unknown" concentrations in the 4 replicate deter-
minations of sample E, with the standard D using TCN and HBB respec-
tively as internal standard . The concentration of the internal 
standard TCN and HBB is equal in ampul D and E. 
Report each individual result for splitless injection respectively on-
column injection (optional) in annex 9. For statistica! treatment 
report three decimal figures (for example 0,258 ~g/ml). 
5. Results/Discussion 
Ten laboratorles reported results of splitless injection, five labora-
torles used the on- column injection and one laboratory used direct 
injection. Laboratory 9 and 10 compared splitless and on-column injec-
tion on the same capillary column. A summary of the gaschromatographic 
conditions is given in table 1. 
One of the main objects in this ringtest was to became conscious of 
aspects which can influence the results. The results of the experi-
ments are discussed below. 
5.1 Sp1itless injection 
5.1.1 Determination of the minimum closing time of the selitter 
The closing time of the splitter wi ll be influenced a .o. by the 
type of gaschromatograph, the volume of the injector, the injection 
volume and injection temperature. In principle it is possible to 
calculate from the internal volume of the injector and the actual flow 
through the capillary column the minimum closing time of the 
splitter . 
The reported closing times, obtained with the test compound PCB 153 and 
an injection volume of 1 ~1, ranged from 30 to 300 seconds . This means 
that with larger injection volumes the closing time should be longer. 
Host of the laboratorles used a closing time between one and two minu-
tes . In the table below the results from three laboratorles using a 
Carlo Erba 4160 gaschromatograph are given . 
lab.no. injection flow tested times (s) optimum closing 
temp _(°C) (ml/min) time ( s) 
----
1 240 1, 09 6-12- 18-30- 60-120 60 
10 260 1,55 30- 60- 120-180- 240 180 




The relation between the flow and the optimum closing time is quite the 
contrary to what is expected. With a greater flow the optimum closing 
time is expected to be shorter. On the other hand the reported respon-
ses of the single injections at each closing time (not given in table 
1) show minimal differences and should probably be interpreted as 
equaL 
From all experiments in the different laboratorles one thing is 
obvious, the closing time of the splitter has a great influence on ~1e 
response of the PCB compounds. 
I t is recommendable to check ahmys for maximum response as a func tion 
of closing time of the splitter, keeping in mind that the closing time 
should be as short as possible to prevent matrix residues to enter the 
capillary column. 
5.1.2 Determination of the optimum initial oven tempersture 
The optimum initial oven temperature will a.o. be influenced by the 
used solvent (iso- octane BPt 99°C), the actual tempersture in the 
beginning of the capillary column and the injection inlet temperature. 
In the optimization procedure it was not clearly indicated which cri-
terion should be usecl. In most cases the partleipants choose the peak 
symmetry as criterion, a few others used peak resolution between the 
PCB-compounds 153/138 or a combination of both parameters. 
As a result most of the laboratorles choose as initial temperature 
90°C, a few respectively 70, 100 and 120°C. 
The initial oven temperature did not influence peak resolution to a 
high ex tent. 
Labaratory 10 reported that, by ~-1rapping the capillary column in alu-
mina foil, the repeatability of the peak \-lid th is much better, pro-
bably due to less tempersture fluctuations in the column oven 
resulting in an improved resolution. The retentien time for the inter-
na! standard HBB decreased with 8%. 
The results of the peak symmetry of PCB compound 153 sho"7 more 
varlation \-lith different initial oven temperatures. For all labora-
torles the peak symmetry of PCB compound 153 (for definition see 
chapter 4.2.2) ranges from 0,49-1,35 at the choosen optimal initial 
oven temperature . 
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In general '~hen the peak s yrumetry i s smaller than 1, 0 the pea k tailing 
can be caused by the followi.ng phenome na: dirty i nlet system (pieces 
of septurn rubber!), dirty detector, injector tempersture too low, poor 
i nj ection technique, floH through detector too low. 
Hhen t he peak symmetry is greater than 1, 0 ,.,e talk of leading peaks , 
This phe nomenon 1·1111 be reached lvhe n the oven tempe r at ure is too lo1•1, 
sample too large or sample capacity too low. 
Labaratory 6 used as optimum initial oven tempersture 100°C in s pite 
of a very lm·l peak symmetry , lolhile the peak symmetry at 90°C 1·1as much 
bet ter . 
Labaratory 12 used as optimum t emperature 120°C, tvhile the bes t 
resolution and symmetry lvere obtained at 90°C. 
l~e have the impression that temperature stability in the oven is of 
great importance for peak ,.,idth and therefore for resolution. The peak 
symmetry '"ill also be i nfluenced by the quality of the capillary 
column. 
It is advised in l iterature by splitless injection to use an i ni.t ial 
oven t empersture 10°C beloH Ute boiling point of the used solvent . In 
t his experiment most of the pa rtietpants us ed as optimum i ni tial oven 
t e mperature 90°C l>lhic h is in agreement 1nth the boiling point of the 
solvent (iso-octane BPt 99 °C). 
One mus t realize that the temperatures read on the display or pyro-
meter not necessarily means t he actual temperature at the point of 
i nterest . I n this respect ex perience of lab 7 using on column i njec-
tion ( see beloH) is illustrative. A temperature differ e nce of * 20°C 
Has fo und be tween the tempers ture at the oven-roof and the centre of 
the oven ( see 5.2 .1). 
5 .1. 3 Determination of the optimum injector temperature 
The optimum i njection temperature ,.,as tested in the range 150 to 
280°C . As a result ,.,e observed nO\v in comparison with t he first 
ringtest i n most cases a higher i njec tor temperature, in s pite of the 
fact that the resolution and peak symmetry were not influenced at the 
different inlet temperatures to a high extent. La baratory 3 stucl ied 
the i nflue nce on the response of PCB 153 a nd other PCB compound s at 
different inle t temperatures. The response 1o1as higher at higher injec-
tion temperatures especially for the later elut i ng compound s . 
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The question arose how far other partielpants observed this effect too 
(but did not report) as already suggested in the second sentence of 
this paragraph. 
In conclusion it seems that resolution and peak symmetry are not t he 
most important parameters for determining the optimum injector tem-
perature. Peak response, especially of later elut ing compounds, is and 
should in any case be used for future optimization experiments. 
Also the question arises what is the influence of the injection tem-
pe rsture on t he closing time of the splitter. 
It is probably advisable first to optimize for injector temperature 
and than for column initia! temperature . 
5.2 On-column injection 
As already indicated in the optimization procedure a detailed proce-
dure could not be given because of the great variety of on-column 
injectors . The Carlo Erba 4160 on-column injector for instanee is 
equiped with a secondary cooling. As these differences can be impor-
tant, but not knO\m to the authors, discussing the results is dif-
ficult. Each participant should ftnd out, for his own equipment, 
procedures and parameters to use for optimization. 
5 . 2.1 Determination of the optimum initia! oven tempersture 
The optimum initia! tempersture will a . o. he influenced by t he used 
solvent (iso-octane BPs 99°C) and the actual tempersture in the part 
of the column in '~hich the sample is injected. From loTOrk reported by 
Grob the best initial oven tempersture '~ould he 10 degrees above t he 
boiling point of iso-octane . The choosen ternperatures vary ho,~ever 
from 70 to 150°C. 
Labaratory 7 reported a difference between the adjusted oven tem-
persture and the tempersture at the oven roof , which influence the 
actual tempersture of the on-column injector. At an adjusted initial 
column oven tempersture of 130°C the tempersture at the injection 
point \oTas ll2°C. At an adjusted tempersture of 110°C (resulting in 
95°C at the point of injection) peak splitting occured. 
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We observed also peak splitting from the chroruatograms of laboratory 4 
and 8, respectively using an initial oven tempersture of 70°C and 
90°C . 
Labaratory 10 tested the range 70- 190°C in steps of 20°C and observed 
some peak splitting at 70°C. Though there was hardly an influence on 
peak resolution and peak symmetry best resolution ,.,as obtained at an 
initial oven tempersture of 150°C. 
The parameters peak resolution and peak symmetry are of no use when 
peak splitting occurs . 
5.2.2 Determination of the optimum starting time for temperature 
programming 
The partielpants tested the range 0- 3 minutes. Host of the labora-
torles used, based on peak symmetry, as optimum starting time 1 
minute. 
There '•Tas little difference in resolution of PCB 153/138 and also in 
peak symmetry. The chromatograms of laboratory 8 which started tempe-
rsture programming af ter 20 seconds shoHed peak split ting. The tested 
parameters are then of no use. 
5 . 3 Linearity test 
All laboratories, except laboratory 8, carried out the linearity test . 
The tested range covered in all the laboratorles the concentratien of 
the PCB compounds in the test sample. When platting height/mass ver-
sus injected mass of PCB 153 it is strildng that, except for labora-
tory 9, the ratio peak height/mass for the lowest concentratien is 
abo1ays higher than the ratio peak height/mass for the highest in jee ted 
mass of PCB 153. In other ,.,ords a higher respons at lower in jee ted 
quantities . The differences in respons between the highest and lowest 
injected quantity varies from 6 to 28%. (Realize that the tested range 
only covered a factor 5 between lewest and highest concentration.) As 
far as we know nobody corrected the results of the test sample E for 
this deviation . In our apinion this effect is caused by the linearizer 
of the gaschromatograph. In our laboratory a reverse effect is 
obtained with gaschromatographs equiped with an electrometer . There-
fore it is recommendable to analyse samples close to the concentratien 
level in the standard by concentrating or diluting the sample or to 
make corrections for linearity deviations . 
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5 .4 Test sample 
The results for the ' PCB compounds 28, 52 , 101, 118, 153, 138 and 180 
obtained by splitleas injection are given in the tables 2-8. The 
results for the on-column injection are given in tables 9- 15. In these 
tables lab no. 5 is also included, though a direc t injection technique 
is used. 
The results of lahoratory 2 , 4, 5, 7, 8 , 11 and 13 have bee n rounded 
off. 
Labaratory 6 reported results calculated on peak height and peak area, 
only the results on peak he ight have been used. Hlstakes in the calcu-
lation of laboratory 2, 5 and 13 have been corrected; a1so an 
interchange of the results of laboratory 5 for the PCB compounds 138 
and 180 has been corrected. 
Laboratory 3 reported an interte renee ~nth the PCB compound 52. There-
fore they usually use another t emperature program to avoid tl1is pro-
blem. Other laboratorles did not report this problem. 
Only in the chromatograms of laboratory 4 a nd 9 ~"e observed many extra 
peaks. 
Laboratory 10 (for both injection techniques) used in first instanee a 
Hamilton 7000 1 ~1 micro syringe (full syringe capacity in the needle) 
resulting in extra peaks. After changing to a 10 ~1 Hamilton 700 micro 
syringe there were no problems anymore. Also the repeatability of the 
injection l-'as improved. 
Laboratory 7 using on- column injection reports following. 
"Experience has suggested that the right tec hnique in sample introdue-
tion is essential for good reproducible data. 
There are a number of t echniques for filling syringes for cold on-
column injection. 
(a) l~ash syringe ~o~ith solvent. Fill needle volume 1olith solvent ; place 
needie in sample ; withdraw 1 ~1 sample; remove syringe; dra w sample 
into barrel. Inject. 
(b) As in (a) but do not draw sample back into barrel. 
( c) Hash syringe 1olith solvent . \Vithdra1o1 needie volume 1 ~1 to leave an 




(d)d Wash syringe thoroughly with the sample . Withdraw the needle 
volume and required sample volume . Remove syringe from the sample, 
withdraw sample into the barrel. Inject. 
All four techniques have been tried. The greatest response and the 
most reproducible concentrations were detected when method (d) was 
used. There is complete continuity of sample inside the syringe and 
only the injection volume is expelled. lts main disadvantage is that 
the needle volume has to be rinsed thoroughly with clean solvent and 
then the next sample to prevent carryover . However this can readily be 
checked by injecting pure solvent. This has been done and no carryover 
of sample or standards over two orders of magnitude difference in 
strength, has been observed." 
Labaratory 5 used a direct injection technique . Because this technique 
is more related to on- column injection, the results have been taken 
up in the tables 9-15. An advantage of this technique is that it can 
be automatized . 
Only laboratory 9 and 10 reported results ~-1ith splitless- and on-column 
injection using the same capillary column and instrument. The chro-
matograms of both laboratorles show better chromatograms with 
splitless injection due to more tailing and peak broadening with on-
column injection . 
For all partleipants a big difference in the response of HBB to the 
PCB'swas observed (ranging from 1.2 to 3.1 for compound 180). 
6 . Statistica! treatment 
6.1 Variatiens between laboratorles 
Many factors are influencing the varianee in an analytica! method 
(operator, apparatus, laboratory, interval of time). 
In the repeatability these factors will be held constant, ~-1hile in the 
reproducibility these factors are variable. 
Definitions (according to ISO 5725 - Precision of test methods -
Determination of repeatability and reproducibility by interlaboratory 
tests). 
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The repeatability r is the value below which the absolute difference 
between two single test results obtained with the same method on iden-
tical test material, under tl1e same conditions (same operator, same 
apparatus, same laboratory, and a short interval of time), may he ex-
pected to lie with a specified probability; in the absence of other 
indications, the probability is 95%. 
r = 2Vo-2cr> + (J2cr> = 2,83 crcr> , in ~~hich o-2 cr> 
laboratory; all factors constant. 
varianee i n a 
The reproducibility R is the value below which the absolute difference 
between two single test results obtained with the same method on iden-
tical test material, under different conditions (different operators, 
different apparatus, different laboratorles and/or different time), 
may he expected to lie ~>~ith a specified probability; in the absence of 
other indications , the probability is 95%. 
2" 83 0'"" (R), 
in ,.,hich (} 2(R) = varianee bet,.,een laboratorles. Days, apparatus , 
operators, all factors differ. 
From r and R the coäfficient of varlation (CV) can be calculated . 
cv er x 100% 
mean value 
R (or r) x 100% 
2, 83 x mean value 
All the results summarized in the tables 2-15 are used for the statistica! 
treatment per PCB compound, per injection methad and per internal 
standard. 
According to ISO 5725 per table and per condition the repeatability, 
the reproducibility and t he coäfficients of varlation are calculated 
a s well as the mean. 
Witl1 the Cochran maximum varianee test the standard deviations of the 
results of each laboratory are tested. With the Dixon's outliertest the 
mean results of each laboratory for all four analyses are tested. The 
chance that a laboratory is wrongly indicated as an outlier is lower 
than 1%. 
8427.14 - 15 -
- 15 -
6, 2 Comparison of the results obtained 1o1ith the interna1 standards TCN 
and HBB 
For each compound and for each injection technique and laboratory the 
laboratory means of the TCN- and HBB- resu1ts are paired, For split-
less- and on-column injection the t-test on the differences between 
the palred values is carried out according to G.w. Snedeeer and W.G. 
Cochran - Statistica! Methods, 1978, page 91-119. 
t = 
Sd 
d mean difference 
n number of palred values 
sd standard deviation of the differences 
6.3 Comparison of the results obtained with the splitless- and on-
column injection 
The laboratory means of the TCN results of the splitless- and the on-
column injection are considered as two indepent groups 1rlth 10 and 5 
values . 
Per group the total mean and the standard deviation between the 
laboratory means is calculated according to G.W. Snedeeer and W. G. 
Cochran - Statistica! Methods, 1978, page 91-119 . 
t , <x1 - x ) V s 12 + s22 2 --
10 5 
x1 = total mean of the TCN results by splitless injection 
x2 = total mean of the TCN results by on-column injection 
s1 = standard deviation between the labora tory means of the splitless 
injection 
s2 standard devia tion bet1o~een the laboratory means of the on-column 
injection 
The same calculation is carried out for the HBB results. 
6 . 4 Results 
In the tables 2-15 the reported results are given in ng/ml. For all 
the results the spike, mean, repeatability (r), reproducibility (R) 
and the co~fficients of varlation (CV) are given. 
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After this first statistica! analysis, laboratorles marked with * con-
tain Outliers according to the Cochrane test. Laboratorles marked ** 
are outliers according to the Dixon test. 
As the authors had the impression that within most laboratorles the 
four injections were carried out on the same day (no instructions 
were given) whereas a few others probably had langer time intervals 
between injections and therefore had more realistic variations between 
the results but therefore also could he considered as outlier with 
the Cochrane test, it was decided to reject nobody because of the 
result of the Cochrane test . Even when these laboratorles should have 
been removed the influence on the reproducibility would have been 
small . 
Only outliers to Dixon were removed, resulting in a new mean, R and r 
(and of course CV's). 
In the splitless mode compound 52 is a special case from statistica! 
point of vue. Labaratory 3 and 14 are considered as "straggler" in the 
Dixon's test. The procedure was than following. First one of the two 
laboratorles (3) ll1as removed and a nell1 statistica! analysis ll1as 
carried out. Now laboratory 14 was a Dixon outlierl Again the sta-
tistica! calculation ll1as carried out now laboratory 14 removed but 
laboratory 3 included. It appeared that now laboratory 3 was an 
outlier. Therefore for this component laboratory 3 and 14 were removed 
for a final calculation. 
As already mentioned in case of the on-column injection technique 
laboratory 5 used a direct injection technique. To show that the 
results for the direct injection technique are not influencing the 
results for the on column technique statistica! calculations have been 
carried out, excluding laboratory 5. There are nearly differences. 
In the table below a summary is given of the co~fficients of variation 
after elimination of the outliers obtained with t he Dixon's test 
for both techniques and both conditions (internal standard TCN and 
HBB). 
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Table Surnmary of coäfficients of variatien (R) 
PCB- Concent ration Internal standard Internal standard 
compound in (ng/ml) TCN HBB 
Standard Test sample Splitless On-column Splitless 
(spike) injection injection inj ec ti on 
28 100 40 9,4 12 , 7 10,4 
52 100 60 7, 0 9, 7 8,2 
101 100 80 6,0 4,8 6, 7 
118 100 100 4,2 3,1 4,6 
153 100 80 3 , 9 8 , 0 5,1 
138 100 40 7,5 8,9 6,1 
180 100 60 7,9 8,3 5 , 5 
From the resul ts in this table in general the lmo~est coëfficient of 
variatien is obtained when the concentratien in the test sample nears 
the concentratien in the standard. Maybe t he above indicated deviation 
of the 1inearity of the system is to a eertaio extent responsible for 
this phenomenom . 
According to paragraph 6 . 2 no significant differences between the 
re sul ts for each injection technique coulrl be found when using TCN or 
HBB as i nternal standard . Apparently this means that in future only 
one of the two internal standards (TCN or HBB) is sufficient for 
calculating PCB concentra tions in samples , \o~hen using peak height. 
Hhen making a choice bet\o~een t he t\o/0 standards one shoulrl reekon \olith 
possib1e interterences from the sample . 
According to paragraph 6.3 in general no significant differences cou1d 
be found between the resu1ts of on-column- or split1ess injection . 
Only for compound 153 and only using HBB as interna1 standard a signi-
ficant dUferenee was obtained bet\o~een splitless inj ection (mean 88 
ng/ml) and on-column injection (mean 93 ng/m1) . 
7. Conclusions 
One of the ma in objects in this ring test \olas to become conscious of 
aspects which can influence the results. From t he reported results '"e 
can give following conclusions . 





9 , 4 
8,7 





a) For optimization of the injector tempersture in splitleas injection 
the peaks response (especially of later eluting compounds) should 
he used. The response of the later eluting PCB compounds is higher 
at higher injector temperatures. It is recommended to use 180. 
b) Using splitleas injection the closing time of the splitter has a 
great influence on the response and retention times of the PCB com-
pounds. It is recommendable to check always for maximum response as 
a function of closing time of the splitter keeping in mind that the 
closing time should be as short as possible to prevent matrix resi-
dues to enter the capillary column. The repeatability of the reten-
tion time should also be checked at the chosen splitter clos!ng 
time. 
c) Tempersture fluctuations in the oven seems to influence strongly 
resolution and peak symmetry. It is advisable to position the 
column so no swinging can occur and/or to wrap the column in alu-
mina foil. For on column techniques see also h. 
d) As with the chosen formula for peak symmetry no asymetric peaks are 
found while inspeetion of the chromatograms shows the contrary, 
another peak height (e.g. at 5% of max. peak height) should be 
used. Therefore visual inspeetion of the chromatagram is important. 
e) The optimum initia! oven tempersture in splitleas injection of 90°C 
is in most laboratorles in agreement with literature, in which an 
optimum initia! oven tempersture is advised 10°C below the boiling 
point, in this case iso- octane (B Pt 99°C). 
f) The linearity of PCB 153 in the tested range is moderate and wil! 
influence the final results. It is recommendable to check the 
linearity for all PCB compounds and to analyse samples close to the 
concentration level in the standard or to make corrections for 
linearity deviations e.g. calibrate by using standards which 
bracket the concentration of the sample. 
g) For splitleas injection the CV (R) varles from 3,9 to 10,4% and for 
the on-column injection from 3,1 to 12,7% for the PCB compounds 28, 
52, 101, 118, 153, 138 and 180. 
h) The chromatograms of all ~aboratories using on-column injection 
show more peak tailing and peak broadening than the chromatograms 
of splitleas injection. 
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This may he related to more optimized circumstances in splitleas 
injection. Because of the different constructions of on-column 
injectors more attention should be given to optimization proce-
dures; the elimination of peak splitting requires futher study. 
i) With the interna1 standarde TCN and HBB no significant differences 
in quantitative results have been found between the results 
obtained for splitless- and for on-column injection. 
j) For splitless- and on-column injection no significant differences 
.in quantitative resu1ts have been found, except for PCB 153 when 
using HBB as internal standard. 
Future work 
In this study no attention was given to optimize separation for 
complicated samples. Therefore in the next PCB ringtest attention 
should be given to the above conclusions. 
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Table 1 Gaschranatographic coOOitions BCR ringtest (2/1983) 
- -
a) Splitless injection (1 'J.,ll) 
Lab. Appa.ratus (type) Detector ColUllD. pbase Length I.d. Film- llnear gas Gas Optimunclosing Opt.imlm injector Temp. prograrrm: 
no. (type) (m) (mn) thickness velocity (type) time splitter (sec)/ temp. (°C)/tested 
(l..m) (c:m/sec) Tested range (sec) range (°C) 
1 Carlo Erba. 4160 Ni 63 SE54 25 0,25 0,20 37 H2 60/6-UO 240/200-240 4 min 90°C- 10°C/min-220°C 
2 HP .5880 A Ni 63 SE54CB 40 0,30-0,32 0,17 34 H2 60/12-60 280/180-280 4 min 90°C- 10°C/mirr220°C 
3 PB 419 Ni 63 CP Sil 8 CB 25 0,23 0,41 27,8 He 300/120-300 240/200-240 6 min 90°C- 10°C/min-220°C 
6 HP 5730 A Ni 63 Methylsili- 12 0,20 0,33 44 He 30/12-60 250/150-250 4 min 100°C- 10°C/mirr220°C 
cone CB 
9 PB 430 Ni 63 CP Sil 5 CB 25 0,23 0,11 39 He 30/12- 132 235/180-235 4 min 70°C-10°C/min-220°C 
10 Carlo Erba. 4160 Ni 63 CP Sil 5 CB 25 0,32 0,44 29 He 180/30-240 260/200-280 4 min 90°C- 10°C/mirr220°C 
11 HP .5880 Ni 63 BP1 25 0,22 0,25 25,4 He 90/60-120 230/210-270 4 min 90°C-10~C/mirr220°C 
12 Carlo Erba. 4160 Ni 63 CN 101 21 0,31 0,17 36 H2 U0/20-UO 240/180-260 4 min 120°C- 10°C/mirr220°C 
13 Carlo Erba. 2101 Ni 63 CN1 50 0,2 0,11 36 H2 120/12- 360 225/175-275 4 min 90°C- 10°C/mirr220°C 
14 HP 5880 A Ni 63 ov 101 25 0,22 n.r. 25 He 60/12-120 200/180-240 4 min 90°C- 10°C/mirr220°C 
15 Vari.an 3700 Ni 63 SE 30/SE 54 50 0,28 0,07 24 N2 120/U- 180 240/180-240 4 min 90°C- 10°C/mirr220°C 
1/1 
b) Orrcolunn injection (1 'J.,ll) 
2 HP 5880 A Ni 63 SE54CB 40 0,30-0,32 0,17 34 H2 - - 1 min 70°C-10°C/mirr220°C 
4 Carlo Erba. 4160 Ni 63 CN1 25 0,32 0,10 33 H2 - - 1 min 70°C-10°C/mirr220°C 
7 Vari.an 3700 Ni 63 CP Sil 8 CB 25 0,22 0,12 28 He - - 1 min 130°C-10°C/min-220°C 
8 PB 427 Ni 63 Methylsili- 25 0,31 0,52 25 He - - 0,33 min 90°C- l0°C/mirr220°C 
cone CB 
9 PB 430 Ni 63 CP Sil 5 CB 25 0,23 0,11 n.r. N2 - - 1 min 110°C-10°C/min-220°C 
10 Carlo Erba. 4160 Ni 63 CP Sil 5 CB 25 0,32 0,44 29 He - - 1 min 150°C-10°C/min-220°C 
15 Vari.an 3700 Ni 63 SE 30/SE 54 50 0,28 0,07 24 N2 - - 0 min 80°C- 10°C/mirr220°C 
1/1 
c) Direct injection (1 'J.,ll) 
5 Vari.an 3700 Ni 63 SE54CB 40 0,32 0,3 50 ·(at 260°C) H2 - - 1 min 160°C-3°C/min-260°C 
n.r. = not reported 
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Table 2 Results Splitless Injection PCB compound 28 (ng/ml) 
Internal standard TCN Internal standard HBB 
Lab.no . 1 : 47 46 45 45 Lab.no . 1 : 46 43 45 43 
Lab.no. 2: 41 40 41 41 Lab.no . 2 : 44 40 41 38 
Lab.no. 3: 41 40 40 42 Lab . no . 3: 40 39 40 40 
Lab.no. 6: 46 47 47 46 Lab . no . 6 : 46 47 46 46 
Lab . no . 9: 36 40 40 38 * Lab . no . 9 : 36 50 40 38 
Lab . no . 10 : 51 52 53 52 Lab .no . 10 : 52 52 53 53 
Lab . no . 11 : 41 44 45 45 Lab . no . 11: 43 47 43 45 
Lab. no . 12 : 43 43 43 44 Lab . no . 12: 45 46 42 48 
Lab.no . 13: 42 42 43 46 Lab . no . 13 : 47 49 38 43 
Lab . no . 14: 42 39 44 42 Lab . no. 14 : 42 39 42 41 
Lab.no . 15: 42 42 44 45 Lab . no . 15 : 44 44 47 44 
All laboratories: All laboratories 
Spike 40 Spike 40 
Mean 44 Mean 44 
Repeatability (r) 4 CV(r) 3,1% Repeatability ( r) 8 CV(r) 6 , 3% 
Reproducibility (R) 11 CV(R) 8,7% Reproducibility (R) 12 CV(R) 9,8% 
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Table 3 Results Splitless Injection PCB compound 52 (ng/ml) 
Internal standard TCN Internal standard HBB 
Lab . no. 1 : 68 67 66 66 Lab . no . 1 : 65 65 65 64 
Lab . no . 2: 65 64 65 64 Lab. no . 2 : 69 64 65 61 
* Lab. no . 3: 87 86 126 74 * Lab .no. 3: 83 83 123 70 
Lab . no . 6: 69 69 70 70 Lab . oo . 6: 70 69 69 69 
Lab . no. 9 : 62 64 64 62 Lab . oo . 9 : 62 66 66 62 
Lab . no . 10: 74 74 76 76 Lab . no . 10 : 76 76 77 76 
Lab . no. 11: 61 61 70 65 Lab . no. 11 : 64 65 68 66 
Lab . no . 12 : 68 64 62 62 Lab.no. 12 : 71 69 60 68 
Lab.no . 13 : 63 62 62 60 Lab . no . 13 : 71 72 55 56 
Lab . no. 14 : 78 82 93 86 Lab . oo . 14 : 79 82 87 84 
Lab.oo . 15: 64 64 67 71 Lab . oo . 15 : 66 67 72 72 
All laboratories : All laboratories 
Spike 60 Spike 60 
Meao 70 Meao 71 
Repeatability (r) 21 CV(r) 10, 5% Repeatability (r) 22 CV(r) 11 , 1% 
Repr oducibility (R) 34 CV(R) 17, 0% Reproducibility (R) 31 CV(R) 15 ,6% 
Without lab . no . 3 (see text 5 . 4) Without lab. no . 3 (see text 5 . 4) 
Spike 60 Spike 60 
Meao 68 Meao 69 
Repeatability (r) 8 CV(r) 4,3% Repeatability (r) 11 CV(r) 5,6% 
Reproducibility (R) 13 CV(R) 10,9% Reproducibility (R) 20 CV(R) 10,4% 
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Table 4 Results Splitless Injection PCB compound 101 (ng/ml) 
Interna1 standard TCN Internal standard HBB 
Lab . no . 1: 86 86 84 83 Lab . no . 1: 82 82 84 78 
Lab . no . 2: 81 80 82 81 Lab . no . 2: 87 80 81 76 
Lab . no. 3: 83 80 82 82 Lab . no . 3: 79 77 80 78 
Lab.no . 6: 82 82 83 84 Lab.no . 6 : 83 82 81 83 
Lab.no. 9: 78 76 80 80 Lab.no. 9: 78 78 82 80 
Lab.no . 10 : 85 87 86 87 Lab . no . 10 : 87 88 88 87 
Lab . no. 11 : 87 89 93 89 Lab . no . 11: 91 94 91 95 
Lab . no . 12: 78 77 81 77 Lab .no . 12: 80 82 79 84 
Lab . no. 13 : 81 75 82 80 * Lab . no. 13: 91 88 72 75 
* Lab . no . 14: 82 80 95 82 Lab . no. 14: 82 80 89 80 
Lab . no . 15: 81 78 80 81 Lab . no . 15: 84 82 86 84 
All laboratories: All laboratories 
Spike 80 Spike 80 
Mean 82 Mean 83 
Repeatability (r) 8 CV(r) 3,3% Repeatability (r) 10 CV(r) 4,5% 
Reproducibility (R) 12 CV(R) 5,1% Reproducibility (R) 15 CV(R) 6,2% 
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Table 5 Results Splitless Injection PCB compound 118 (ng/ml) 
Internal standard TCN Internal standard HBB 
Lab . no . 1: 102 104 100 101 Lab.no . 1 : 98 98 100 97 
Lab . no . 2: 102 104 104 105 Lab.no. 2 : 113 105 105 100 
Lab.no. 3: 102 101 101 103 Lab . no. 3 : 97 98 98 98 
Lab . no . 6: 101 102 102 101 Lab . no . 6: 103 102 100 100 
Lab .no . 9: 106 102 98 106 Lab . no . 9: 108 106 102 104 
Lab.no . 10: 99 102 102 104 Lab.no. 10: 101 104 104 102 
Lab.no . 11: 97 97 100 98 Lab.no. 11: 102 102 96 99 
Lab.no . 12: 93 95 100 95 Lab . no . 12: 96 102 96 104 
Lab . no. 13: 91 91 98 96 * Lab . no . 13 : 102 106 87 90 
Lab.no . 14: 104 100 109 109 Lab . no. 14 : 104 100 103 106 
Lab . no. 15 : 93 97 92 100 Lab . no . 15: 96 101 99 99 
All laboratories: All laboratories 
Spike 100 Spike 100 
Meao 100 Mean 101 
Repeatability (r) 8 CV(r) 2, 7% Repeatability (r) 11 CV(r) 3,8% 
Reproducibility 1R) 13 CV(R) 4,4% Reproducibility (R) 13 CV(R) 4,5% 
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Table 6 Results Splitless Injection PCB compound 153 (ng/ml) 
Internal standard TCN Internal standard HBB 
Lab . no . 1: 90 86 88 88 Lab.no. 1 : 87 82 87 85 
Lab . no. 2: 89 91 89 91 Lab . no . 2 : 98 91 89 86 
Lab.no . 3 : 92 89 91 90 Lab . no . 3 : 88 86 89 86 
Lab . no. 6 : 88 87 88 88 Lab . no . 6 : 90 87 86 87 
Lab . no . 9 : 90 94 96 92 Lab . no . 9 : 90 98 98 92 
Lab . no. 10 : 87 85 88 86 Lab . no . 10 : 88 87 88 84 
Lab. no . 11 : 84 86 89 84 Lab. no . 11: 88 92 85 84 
Lab. no . 12: 87 86 83 85 Lab . no . 12 : 90 92 80 80 
Lab . no . 13: 83 78 90 87 Lab . no . 13: 93 91 80 81 
Lab . no . 14: 87 87 93 87 Lab . no. 14 : 87 87 87 85 
Lab.no . 15 : 88 88 87 96 Lab . no. 15 : 91 91 94 94 
All laboratories : All laboratories 
Spike 80 Spike 80 
Mean 88 Mean 88 
Repeatability (r) 8 CV(r) 3 , 0% Repeatability (r) 11 CV(r) 4,3% 
Reproducibility (R) 10 CV(R) 3,9% Reproducibility (R) 13 CV ( R) 5,1% 
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Table 7 Results Splitless Injection PCB compound 138 (ng/ml) 
Internal standard TCN Internal standard HBB 
Lab . no . 1: 52 50 46 48 Lab.no. 1: 50 48 46 46 
Lab . no. 2: 45 44 43 45 Lab.no . 2: 49 45 43 43 
Lab.no. 3: 43 43 44 44 Lab . no. 3: 41 41 43 43 
Lab . no. 6 : 44 44 47 46 Lab.no. 6: 45 44 46 46 
Lab.no. 9: 44 44 42 42 Lab . no. 9: 44 46 42 42 
Lab.no . 10: 46 49 47 47 Lab.no . 10 : 47 49 48 46 
Lab . no. 11: 40 40 43 40 Lab . no. 11: 42 43 42 41 
Lab.no. 12: 47 47 47 47 Lab . no. 12: 49 47 45 44 
Lab.no. 13: 35 38 47 45 Lab.no. 13: 39 45 41 42 
* Lab . no . 14: 43 43 45 44 Lab.no. 14 : 43 43 43 43 
Lab.no. 15 : 44 43 41 52 Lab.no. 15: 46 45 44 51 
All laboratories: All laboratories 
Spike 40 Spike 40 
Mean 45 Mean 45 
Repeatability (r) 7 CV(r) 5,7% Repeatability (r) 5 CV(r) 4,3% 
Reproducibility (R) 10 CV(R) 7,5% Reproducibility (R) 8 CV(R) 6,2% 
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Table 8 Results Splitless Injection PCB compound 180 (ng/ml) 
Internal standard TCN Internal standard HBB 
Lab . no . 1: 67 68 68 66 Lab . no . 1: 64 64 68 64 
Lab.no . 2: 61 62 60 62 Lab . no . 2: 67 6S 63 62 
Lab. no . 3: 63 62 63 6S Lab . no. 3: 60 60 62 62 
Lab .no . 6: 62 63 64 6S Lab.no . 6: 63 63 63 6S 
Lab . no . 9: 68 S6 S4 S8 * Lab . no . 9 : 68 S8 S6 S8 
Lab . no. 10: 61 64 6S 64 Lab.no. 10: 62 6S 6S 62 
Lab . no . 11: 61 62 68 62 Lab.no. 11 : 64 6S 6S 63 
Lab.no . 12: S7 S9 6S 61 Lab . no. 12 : S9 62 63 S7 
* Lab . no. 13: 48 4S 66 66 Lab . no. 13 : ss S3 S8 61 
Lab.no. 14: 6S 63 67 64 Lab.no. 14 : 6S 63 63 62 
Lab . no . 1S: 63 62 S9 66 Lab. no. 15: 64 65 64 65 
All laboratories: All laboratories 
Spike 60 Spike 60 
Mean 62 Mean 62 
Repeatability (r) 12 CV(r) 7,0% Repeatability (r) 7 CV(r) 3,9% 
Reproducibility (R) 14 CV(R) 7,7% Reproducibility (R) 10 CV(R) 5,3% 
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Table 9 Results On-Column Injection PCB compound 28 (ng/ml) 
Interaal standard TCN Interaal standard HBB 
Lab.no. 2: 41 41 39 38 Lab . no . 2: 42 42 42 39 
Lab.no . 4 : 40 40 40 40 Lab . no . 4: 39 39 39 39 
Lab . no . 5: 39 39 40 37 Lab . no . 5 : 39 36 35 33 
Lab . no . 7: 44 43 45 46 Lab . no . 7: 44 42 45 46 
Lab. no . 8: 53 53 52 54 Lab.no . 8: 53 53 50 51 
Lab . no . 9: 38 41 40 38 Lab . no. 9 : 46 52 50 45 
Lab.no. 10: 48 47 46 48 Lab . no . 10: 50 50 50 51 
Lab . no. 15: 44 43 44 Lab . no. 15: 42 43 43 
All laboratories : All laboratories 
Spike 40 Spike 40 
Mean 43 Mean 44 
Repeatability (r) 3 CV(r) 2 , 6% Repeatability (r) 5 CV(r) 4 , 1% 
Reproducibility (R) 14 CV(R) 11,8% Reproducibility (R) 17 CV(R) 13,3% 
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Table 10 Results On- Column Injection PCB compound 52 (ng/ml) 
Internal standard TCN Internal standard HBB 
Lab . no. 2 : 66 64 66 65 Lab . no . 2 : 67 65 67 65 
Lab . no . 4: 66 65 65 65 Lab. no . 4: 64 64 64 64 
Lab. no . 5: 59 63 69 63 Lab . no . 5: 59 59 59 56 
Lab . no . 7: 67 65 68 68 Lab.no. 7: 67 64 67 68 
Lab . no . 8: 75 73 74 75 Lab . no. 8 : 76 73 71 70 
Lab . no. 9: 62 58 59 58 Lab.no . 9 : 74 73 73 67 
Lab.no. 10: 54 59 66 65 * Lab.no . 10: 56 62 71 69 
Lab.no. 15 : 73 64 68 Lab.no . 15: 71 64 66 
All laboratories: All laboratories 
Spike 60 Spike 60 
Mean 65 Mean 66 
Repeatability (r) 8 CV(r) 4,6% Repeatability ( r) 9 CV(r) 4,8% 
Reproducibility (R) 15 CV(R) 8,2% Reproducibility (R) 15 CV(R) 8,1% 
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Table 11 Results On- Column Injection PCB compound lOl (ng/ml) 
Internal standard TCN Internal standard RBB 
Lab . no . 2 : 80 80 76 75 Lab .no . 2 : 81 82 81 76 
Lab.no. 4 : 84 82 82 82 Lab . no . 4 : 82 81 81 81 
Lab.no. 5: 78 80 78 80 Lab.no. 5 : 78 74 86 89 
Lab. no . 7 : 81 81 79 80 Lab . no . 7 : 81 79 79 80 
Lab. no . 8 : 83 85 88 90 Lab. no . 8 : 84 85 84 84 
Lab. no . 9 : 85 80 78 78 Lab. no . 9 : 102 103 97 91 
Lab .no. 10: 89 87 85 89 Lab . no . 10: 92 92 92 94 
Lab . no. 15: 89 84 85 Lab . no . 15 : 86 84 82 
All laboratories : All laboratories 
Spike 80 Spike 80 
Mean 82 Mean 84 
Repeatability (r) 6 CV(r) 2,7% Repeatability (r) 8 CV(r) 3,4% 
Reproducibility (R) 12 CV(R) 5,1% Reproducibility (R) 24 CV(R) 10,1% 
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Table 12 Results On-Column Injection PCB compound 118 (ng/ml) 
Internal standard TCN Internal standard HBB 
Lab.no . 2: 101 100 94 88 Lab.no . 2: 103 102 100 92 
Lab.no. 4: 103 102 102 102 Lab . no. 4 : 100 100 101 101 
Lab . no. 5: 89 94 95 102 Lab . no. 5 : 89 87 67 71 
Lab . no . 7: 100 103 98 98 Lab . no. 7: 100 100 98 99 
Lab.no . 8 : 100 102 101 101 Lab . no. 8: 101 102 96 95 
Lab. no. 9: 97 95 97 100 Lab. no . 9: 117 121 121 116 
Lab . no. 10: 108 104 102 104 Lab . no . 10: 112 110 ll1 114 
Lab.no . 15: 105 101 102 Lab.no. 15: 101 101 98 
All laboratories : All laboratories 
Spike 100 Spike 100 
Mean 100 Mean 102 
Repeatability (r) 9 CV(r) 3,3% Repeatability (r) 8 CV(r) 2,9% 
Reproducibility (R) 13 CV(R) 4,5% Reproducibility (R) 28 CV(R) 9,9% 
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Table 13 Results On- Column Injection PCB compound 153 (ng/ml) 
Internal standard TCN Internal standard HBB 
Lab . no . 2: 89 88 83 83 Lab . no. 2: 90 89 88 84 
Lab.no . 4 : 94 91 92 92 Lab . no . 4 : 91 90 90 90 
Lab.no . 5 : 85 89 96 87 Lab . no . 5: 85 83 81 90 
Lab.no . 7 : 89 90 88 89 Lab . no . 7: 89 88 88 90 
Lab . no . 8 : 94 94 97 100 Lab . no . 8 : 95 94 92 93 
Lab. no . 9 : 83 76 76 79 Lab . no . 9 : 100 97 95 92 
Lab . no . 10: 95 93 92 96 Lab .no . 10 : 98 98 99 lOl 
Lab.no . 15 : 89 87 90 Lab . no . 15 : 86 87 86 
All laboratories : All laboratories 
Spike 80 Spike 80 
Mean 89 Mean 91 
Repeatability (r) 8 CV(r) 3,1% Repeatability (r) 6 CV(r) 2,3% 
Reproducibility (R) 17 CV(R) 6,8% Reproducibility (R) 16 CV(R) 6,4% 
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Table 14 Results On-Column Injection PCB compound 138 (ng/ml) 
Internal standard TCN Internal standard HBB 
Lab.no. 2: 39 40 37 40 Lab . no . 2: 39 40 38 40 
Lab . no . 4 : 44 43 43 43 Lab.no . 4 : 42 42 42 42 
Lab . no. 5: 50 45 46 50 * Lab.no. 5: 50 42 39 44 
Lab . no . 7 : 44 45 44 44 Lab . no . 7 : 44 44 44 44 
Lab. no . 8 : 48 45 47 49 Lab . no. 8 : 49 45 45 46 
Lab. no . 9 : 38 37 38 38 Lab. no . 9 : 45 47 48 44 
Lab . no . 10: 46 47 46 48 Lab . no . 10: 48 50 50 51 
Lab . no . 15: 43 43 45 Lab.no . 15: 42 46 44 
All laboratories: All laboratories 
Spike 40 Spike 40 
Mean 44 Mean 45 
Repeatability (r) 4 CV(r) 3, 1% Repeatability (r) 6 CV(r) 4,7% 
Reproducibility (R) 11 CV(R) 9,0% Reproducibility (R) 10 CV(R) 8,2% 
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Table 15 Results On-Column Injection PCB compound 180 (ng/ml) 
Internal standard TCN Internal standard HBB 
Lab . no . 2 : 60 60 56 58 Lab. no. 2: 60 61 59 58 
Lab . no . 4: 65 62 62 64 Lab . no . 4: 63 60 61 63 
Lab .no. 5: 70 66 70 74 Lab . no . 5: 70 62 82 78 
Lab . no . 7: 62 62 63 62 Lab .no . 7 : 62 60 63 63 
Lab.no . 8 : 66 64 69 69 Lab . no. 8: 68 64 65 65 
Lab.no . 9 : 55 52 56 54 Lab .no . 9 : 58 59 61 55 
Lab.no. 10 : 64 68 66 64 Lab . no . 10: 68 72 7l 68 
Lab . no . 15 : 62 59 62 Lab . no . 15 : 60 60 60 
All laboratories : All laboratorfes 
Spike 60 Spike 60 
Mean 63 Mean 63 
Repeatability (r) 6 CV(r) 4 , 6% Repeatability (r) 6 CV(r) 3,6% 
Reproducibility (R) 15 CV(R) 12,0% Reproducibility (R) 12 CV(R) 6,8% 
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a) For optimization of the injector temperature in splltless injection 
the peaks response (especially of later eluting compounds) should 
he used . The response of the later e1uting PCB compound s is higher 
at higher injector temperatures. It is recommended to use 180. 
b) Using splitless injecti.on the closing time of the splitter has a 
great influence on the response and retention times of the PCB com-
pounds. It is recommendable to check ahmys for maximunt response as 
a function of closing time of the splitter keeping in mind that the 
closing time should he as short as possible to prevent matrix resl-
dues to enter the ca pillary column. The repeatability of the reten-
tion time should also be checked at the chosen splitter closing 
time. 
c) Temperature fluctuations in the oven seems to influence strongly 
resolution and peak symmetry . It is advisable to position the 
column so no swinging can occur and/or to \>Trap the column in alu-
mina foil. For on column techniques see also h . 
d) As ~dth the choscn formula for peak symmetry no asymetric peaks are 
found while inspeetion of the chro1oatograms sho\oTS the contrary, 
another peak heieht (e.g. at 5% of max. peak height) should he 
used. Therefore visual inspeetion of the chromatagram is important. 
e) The optimum initia! oven temperature in splitleas injection of 90°C 
is in most laboratodes in agreement \'lith literature, in which an 
optimum initial oven temperature is advised 10°C below the boiling 
point, in this case iso-octane (B Pt 99°C). 
f) The linearity of PCB 153 in the tested range is moderate and ~-1ill 
influence the final resul ts. It is recommendable to check the 
linearity for all PCB compound s and to analyse samples close to the 
concentratien level in the standard or to make correctloos for 
linearity deviat.i.ons e.g . caU.brate by using standards which 
bracket the concentration of the sample. 
g) For Dplitless injection the CV (R) varles from 3, 9 to 10,4% and for 
the on-column injection from 3,1 to 12,7% for the PCB compounds 28, 
52, 101, 118, 153, 138 and 180. 
h) The chromatograms of all laboratorles using on- column injectlon 
shm-1 more peak tail ing and peak broadening than the chromatag rams 
of splitless injection. 
8427.18 - 19 -
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This roay be related to more optimized circumstauces in splitleas 
injection. Because of the different constructions of on-column 
injectors more attention should be given to optimization proce-
dures; the elimination of peak splitting requires futher study. 
i) With the internal standards TCN and HBB no significant differences 
in quantitative results have been found bet\<Teen the results 
obtalned for splitless- and for on-column injection. 
j) For splitless- and on- column injection no significant differences 
in quantitative results have been found , except for PCB 153 when 
using HBB as internal standard. 
Future work 
In thts study no attenU.on \olas given to optimize separation for 
complicated samples. Therefore in the next PCB ringtest attent ion 
should be given to the above conclusions . 
842 7.19 AR/W 
Tab1e 1 Gaschrcmatographic conditions BCR ringtest (2/1983) 
a) Splitless injection (1 f.l}.) 
Lab. Apparatus (type) Detector Colunn phase Leogth I.d. Film- Linear gas Gas OptimJm closing Optimun injector Temp. prograrme 
no. (type) (m) (mn) thickness velocity (type) time splitter (sec)/ temp. (°C)/tested 
(l.m) (cm/sec) Tested range (sec) range (oC) 
1 Carlo Erba. 4160 Ni 63 SE54 25 0,25 0,20 37 H2 60/6-120 241J/2oo-240 4 min 90°C- l0°C/min-220°C 
2 HP 5880 A Ni 63 SE54CB 40 0,3G-0 ,32 0,17 34 H2 60/12-60 280/18<r280 4 min 90°C-l0°C/min-220°C 
3 PB 419 Ni 63 CP Sil 8 CB 25 0,23 0,41 27,8 He 300/120-300 241J/2oo-240 6 min 90°G-l0°C/min-220°C 
6 HP 5730 A Ni 63 Methylsili- 12 0 ,20 0,33 44 He 30/12-60 250/150-250 4 min l00°C- l0°C/minr220°C 
cone CB 
9 PB 430 Ni 63 CP Sil 5 CB 25 0,23 0,11 39 He 30/12-132 235/l8<r235 4 min 70°C-l0°C/min-220°C 
10 Carlo Erba. 4160 Ni 63 CP Sil 5 CB 25 0,32 0,44 29 He 180/30-240 260/200-280 4 min 90°C-l0°C/min-220°C 
11 HP 5880 Ni 63 BPl 25 0,22 0,25 25,4 He 90/60-120 230/210-270 4 min 90°C-l0°C/min-220°C 
12 Carlo Erba. 4160 Ni 63 OV lOl 21 0,31 0 ,17 36 H2 120/20-120 241J/l8<r260 4 min 120°C- 10°C/minr220°C 
13 Carlo Erba. 2101 Ni 63 OVl .50 0,2 0 ,11 36 H2 120/12-360 225/175-275 4 min 90°C-l0°C/min-220°C 
14 HP .5880 A Ni 63 ov 101 25 0,22 n.r. 25 He 60/12-120 200/180-240 4 min 90°C- l0°C/min-220°C 
b) Oo-colunn injection (1 lll) 
4 Carlo Erba. 4160 Ni 63 ov 1 25 0,32 0,10 33 H2 - - 1 min 70°C-l0°C/minr220°C 
7 Varian 3700 Ni 63 CP Sil 8 CB 25 0,22 0,12 28 He - - 1 min 130°C- 10°C/min-220°C 
8 PB 427 Ni 63 Methylsili- 25 0,31 0,52 25 He - - 0 ,33 min 90°C- l0°C/min-220°C 
cone CB 
9 PB 430 Ni 63 CP Sil 5 CB 25 0,23 0,11 n.r. N2 - - 1 min l 10°C-l0°C/min-220°C 
10 Carlo Erba. 4160 Ni 63 CP Sil 5 CB 25 0,32 0,44 29 He - - 1 min 150°C-l0°C/min-220°C 
c) Direct injection (1 lll) 
5 Varian 3700 Ni 63 SE54CB 40 0,32 0,3 50 (at 260°C) H2 - - 1 min 160°C-3°C/min-260°C 
n . r. = not reported 
. 8427 .20 
f<:~ blr::: 2 Results SPlitless InJection PCB coffiPound ·28 <nS/ffil) 
I raterna 1 standard TCN In t er'nal s tarada t'd H[~B 
L. a i..' • ra o • 1 : 47 46 45 45 Lab.no. 1 : 46 43 •l5 4 3 
L. a i:'.' . no . '} . .:.. . 41 40 41 41 Lab.no. ') . .... 44 40 41 38 
L aLo . ra o . -z • ' J • 41 40 40 42 l.ab.no. 3: 40 39 40 •l 0 
l... <:~ i:.~ . no. {. : 46 47 47 46 Lab, rao. 6! 46 47 46 46 
1-'"~ t..n o . 0. , . 36 40 40 38 l.ab.no. <n -z t. wO 50 40 38 
L. <:: b • ra o • 1 0 ! 51 52 53 52 Lab.no. 10! C''") ...!.:.. 52 53 t:'J! ...Jw 
L. a b , r1o. 1 :L ~ 41 44 45 45 L.ab.no. 1 1 : 43 47 4 :5 4c.-~~ 
L ~~ b 1 n•J . 1 ') • .... 43 43 43 44 Lab.no • 1"')+ .... 45 46 42 48 
L. a b • ra o • 1 ~~ : 42 42 43 46 Lab.no. 13: 47 49 38 43 
'*: / '*:'*< Lab .no . l4: 114 144 169 113 ~:!•• Lab.no. 14! 1.03 130 145 100 
All l a boratories! All laborataries: 
SI"' i k.P 40 SPike 40 
l·i \~=~ ra 53 ~lean 52 
l;:c r .. ·c<:: ta bi l i ts ( I' ) 24 CV(r) 16r2ï. F: e F· e at a b i 1 i t ':1 ( r) 21 CV(r) 14r3ï. 
h: e : .... r- o d u c i b i 1 i t :; ( R > 85 CV<R> 56r'lï. l~eP roduc i b :i.l i ts < R) 70 CV<R> 48r1ï. 
l:J :i. t il OUt l a b. r1o. 1.4 Without lab.no. 14 
: 
:::; ,., i 1 ~. (~ 40 I SPike 40 
I·) r: : ::~ n 44 11ean 44 
F: e ;-:· ,.~ <:} t a b i l i t s < r) 4 CV<r> 2r9ï. RePeat abiJ.it~.:~ ( r) 9 CV(r) 6r8ï. 
1:: t~ r· t' n dIJ c :i. bi 1 i t '.:1 <ro 1.2 CV<R> 9,4ï. ReProducibilit:; (f\) 13 CV<R> 10r4ï. 
* 
I ;; L• .1. •:: ::5 Results SPlitless InJection PCB coruPound 52 Cn~/ml) 
Internal standard TCN 
L. :,;: ÏJ , 1"1 D , 1 : 68 




l...<:::b , nu. -z • ...... 87 
!... a b. r·1o . 6! 69 
J... ;:;(_) • f"ID • C) ! 62 
l...ab,no. 1. 0: 74 
1... a b. r1o. U.: ól 
L<Jb,no. 12! 68 
l._ab. no . l ~~. : 63 
Lab , r·1 n. :1.4! 42 
All laboratories: 
s p :i. k. e 
1-le<::·r, 

























21 CV(r) 11 r1% 
40 CV<R> 21r3% 
t-.lit.hout lab. no. 3 and 14 -' (see text, Dixon stragglers) 
~:~ ;:, i k. ,, ... 
(I·-~ en 
RePcatabilit~ (r) 








Interna l star1dard HBB 
Lab.no. 1. ! 65 
Lab. r1o. r) t À.. • 69 
Lab.no. -z • ,_ .. 83 
Lab.no. 6! 70 
Lab.no. 9! 62 
Lab.no. 10: 76 
Lab.no. 11 : 64 
Lab.no. 12! 71 
Lab.no. 13! 71 






































23 CV(r) 12r2% 
39 CVCR) 20r9% 












T d b l e '1 Results SPlitless InJection PCB co~Pound 101 (ng/ml) 
Ir. te rna 1 standard TCN 
L2 b.nu . 1 : 86 
Lab. r.o. ') . ... . 81 
1... ;:: L•. n n • ..... ,:, . 83 
L:~ b.no. ' . Ci • 0'"> w .:.. 
L. ;3(_:~ ,no, (1: ?8 
l._;:>. b. no. 10! 85 
L.atc, no. 1 1 : 87 
Latc.no. 1 '""). .:.. . 78 
I... a l:•, r1o. t -· • . ,:, . 81 
I. ~>.Ï::O • t'10 + 14: 91 
nll laboratories! 
s f" i~~- t:': 
1-i C: <;; 1'1 
1:: '::·' , ..... _. ::; t ;c; b :i. 1 i t '3 ( r ) 
























11 CV(r) 4,6/. 
14 CV<R> 6,0/. 
Internal standard HBB 
. 
Lab.no. 1 : 82 
Lab.no. .,. ... . 87 
Lab .no. 3: 79 
Lab. r11J. 6! 83 
Lab.no. 9: ?8 
Lab.no. 10! 87 
Lab.no. 1 1 : 91 
Lab. nc1 . 12! 80 
Lab.no. 13! 91 






Without lab . no. 14 
SrJike 
Me ar. 
























17 CV(r) 6,9ï. 




16 cv (f\) 
4,67. 
6,7/. 
I ,:,: i:·· _I ,, -: :=:i Results SPlitless InJection PCB comPound 118 Cns/ml) 
Internal standard TCN 
I . ,::: L< , r, o • 1 : 102 
!.. _,. ;.-.- , no, 'i • 102 ,;_ . 
1. . -.:: f., ' f"l 0 • ·r • 102 ..... . 
L. .: - ~ i .. ' ~ r 1 () ,. ,,_. ··~· .. 101 
1... "'' i.:• , r·, (l , ç, " l • 106 
L.aL•,no. :1.0: <f'7 
L <'~ b , r, o . :t.l. : ~>7 
l...ab.no . :1.2 : 93 
1... ,;; b • n o , 1 -x • ...... + 91 
l... :::: b,r,o. l4 ~ 104 
All laooratories! 
~; : ·· :i. V(:;: 
1·1 ~: "-' r, 







































Internal s t a n d a r d ~m [{ 
Lab.no. 1 : 9H 
Lab.no. '1 • A'., + 113 
Lab .n o • ··z • ___, . 97 
Lab.r.o. 6: 103 
La iJ • r. o • 9: :1.08 
Lab.no . 10! 101 
La iJ • r. o • 11: 102 
Lab.no. 12! 96 
Lab.no. 13! 102 










































Table 6 Results SPlitless InJection PCB comPound 153 < n;:un.l) 
----------------------------------------------------
. --- ----- ·- . -· -· .. ·-··--··------ -· - .. 
Interraal s t a rad a r d TC N Internal standard HBB 
Lab. rro. l.! 90 
Lab.no. 'I + 89 ... . 
Lab.no. 3! 92 
Lab. r.o. 6! 88 
Lat,.no. 9: 90 
Lab. r.o. 10: 87 
Lab.no. 1 1 ! 84 
Lab .no. 12 ! 87 
Lab.no. 13! 83 











































Lab.no. t: 87 
Lab.no. 'I • .... 98 
Lab.no. 7. ...J • 88 
Lab.no. 6! 90 
Lab. rao. 9! 90 
Lab.no. 10! 88 
Lab.no. 1 1 : 88 
Lab.no. 1". ...  90 
Lab. rao. 1'. '-'. 9~3 








































4 r.· "/ 
' -.) '" 
5,1/. 
lE 
Table 7 Results SPlitless InJection PCB comPound 138 <n!:!/ml) 
----------------------------------------------------
Internal standard TCN 
Lab. r.o. 1 ! 52 
Lab.no. '") . .__ . 45 
Lab.no. --z • ~· . 43 
Lab.no. 6: 44 
Lab. r.o. 9! 44 
Lab.no. 10! 46 
La b.no. 1 1 : 40 
Lab.no. 1'">• .... 47 
Lab.no. l3! -ze-..J.J 


































In t e rraal standar-c:i HBB 
Lab.no. 1 ! 50 
Lab. rao. '") . .__ . 49 
Lab. rso. 3! 41 
Lab.no . 6! 45 
Lab.no. 9! 4-'1 
Lab.no. 10! 47 
Lab.no. 1 1 : 42 
Lab.no • 1,.,. .... 49 
Lab .no • 13! 39 











































Table 8 Results SPlitless InJection PCB coruPound 180 (r;s/ml) 
-------- - ------------- - ------ - - ---------- - - ---- - - - --
Internal standard TCN 
Lab.no. 1 ! 67 
Lab. r1o. '1 • 
·-. 
61 
Lab . no. -:r • ~·. 63 
Lab.no. 6! 62 
Lab.no. 9! 68 
Lab.no. 10! 61 
Lab. r·1o. 1 1 : 61 
Lab.no. 1'1• .:..t 57 
Lab.no. 1" . vt 48 











































Internal standard HBB 
Lab.no. u 64 
Lab.no. '1• .:.. . 67 
Lab . no. -:r • '-' . 60 
Lab.no. 6: 63 
Lab.no. 9: 68 
Lab.no. 10: 62 
Lab.no. 1 1 : 6 4 
Lab . no. 12! 59 
Lab.no. 13: c-c· ..;..; 










































4 r 1 ;~ 
5,5/.: 
Table 9 Results On-Column InJection PCB compound 28 (n~/ml) 
Internal standard TCN 
La b . no. 4! 40 
Lab.no. "'" . ,;, 39 
Lab.no. 7! 44 
Lab.no. 8: ~j3 
Lab. r.o. 9: 38 


















..J À.., 54 
40 38 
46 48 
3 CV(r) 2,5ï. 
16 CV<F:> 13,0ï. 







3 ·C V < r ) 2 , 3 ï. 
16 CV<R> 12,7ï. 
- . -· 
Internal standard HBB 
Lab.no. 4! 39 
Lab.no. C:+ ,; . 39 
Lab . no. 7! 44 
Lab.no. 8: r. .... ., ,'j..:J 
Lab. r.o. 9! 46 

















,_. , J 3 ~3 
~c . ,; 46 
::-;o ~:i l 
50 4"" ~J
50 ~':i l 
6 CIJ(r) 4,3ï. 
19 CV<R> 14,8ï. 







5 CV(r) 3,9ï. 
15 CV<R> 11,57. 
Table 10 Results On-Column InJection PCB comPound 52 <n~/ml) 
---------------------------------------------------
Internal standard TCN 
·Lab.no. 4: 66 
Lab.no. C" + J. 59 
Lab.no. 7! 67 
Lë.lb.no. 8! 75 
Lab.no. 9: 62 






























WithoiJt lab.no. 5. (direct injection) 
SPike 
Mean 
ReReatabi lit~ (r) 
ReP rodiJcibilits CR) 
60 
6~) 
8 CV(r) 4t2ï. 




Internal standard Hf:[; 
Lab.no. 4: 64 
Lab . no. C' • • J. 59 
Lab.no. 7: 67 
Lab.no. s: 76 
Lab. rro. 9: 74 





































10 CV<r> 5t4 % 
14 CV<R> 7 ~5z 
Table 11 Results On-Column InJection PCB comPound 101 (nS/ml) 
Internal standard TCN 
Lab. ,-,o. 4 : 84 
Lab.no. C" • J• 78 
Lab.no. 7: 81 
Lab.no. 8: 83 
Lab.no. 9: 85 





































7 · CV<r> 2,71. 
11 CV<R> 4r8i. 
* 
Internal standard HBD 
Lab.no. 4: 82 
Lab.no. c.- • J. 78 
Lab.no. 7: 81 
Lab.no. 8: 84 
Lab.no. 9: 102 





































7 CV<r> 2,9ï. 
23 CV<R> 9r4ï. 
Table 12 Results On-Column InJection PCB comPou~d 118 (n~/ml) 
----------------------------------------------------
Internal standard TCN 
Lab.no. 4: 103 
Lab.no. c:- • ~. 89 
Lab.no. 7! 100 
Lab.no. 8! 100 
L.ab.no. 9! 97 





































5 CV(r) 1,97. 
9 CV<F::> 3d/. 
. 
- ----·-- ---
Internal standa n.i IH<B 
Lab.no. 4: 100 
Lab.no. c: • ~· 89 
Lab.no. 7: 100 
Lab.no • . 8! 101 
Lab.no. 9! 117 



























14 CV(r) 4,91. 
41 CV<R) 14~2/. 







6 CV(r) 2v1Z 
26 CV<R> 8,7/. 
.Table 13 Results On-Column InJection PCB comPound 153 (ng/ml) 
Internal standard TCN 
Lab.no. 4! 94 
Lab.no. .:: . J. 85 
Lab. r.o. 7: 89 
L.ab.no. 8: 94 
Lab. r.o. 9: 83 





































6 CV( r) 2,5ï. 
20 CVCR) s,oz 
4 
Internal standani IIF:B 
Lab.no. 4! 91 
L.ab.no. c.- • J • 85 
Lab.no. 7: 89 
Lab.no. ("\ . 0. 95 
Lab.no. 9: 100 





























6 , 0/. 







5 CV(r) 1,9/. 
13 CV(R) 4,8% 
f ; : b.l. ·:~ l<"' Results On-Column InJection PCB comPound 138 (ng/ml) 
lnterrral. starrda rd TCN 
l... ;:; i_,. no • . 4 : 44 
L a l:,,no. r.:- • 
·-' . ~:;o 
\... a i:. . 1·ro. /: 44 
L a t:• . rro. ·::· . 48 IM,• • 
L al.:. . 1·ro. 9: 38 
Lab <!- no. lO! 46 





Without l0b.no. 5. 
~::~ :··  i 1~. e 
11 ~-: ;:_, n 
R e~·ea tabilitY (r) 




























3 CV(r) 2r2:ï. 
11 CV(R) 8r9/. 
* 
In te 1·na l standard HBB 
Lab.no. 4: 42 
Lab.no. c.- • ...; . 50 
Lab.no. 7! 44 
Lab.no. 8: 49 
Lab.no. 9: 45 





































4 CV(r) 2r9:ï. 
9 CV(f\) 6 r8/. 
Tabl e 15 Results On-Column InJection PCB compound 180 <n~/ ml) 
----------------------------------------------~-~----
Internal standard TCN 
Lab.no. 4: 65 
La b.no. <::" • -.} . 70 
Lab.no. 7: 62 
Lab.no. 8: 66 
Lab.no. 9: <-"<::" -.}-.} 





































5 ·C\I(r) 2r8ï. 
15 CV( R) 8,3/. 
In te rr.al standa rd HBEl 
Lab.no. 4: 63 
Lab.no. C" • -.} . 70 
Lab.no. 7: 62 
Lab.no. s: 68 
Lab.no. 9: 58 
Lab.no. 10: 68 
All labo r ato ries: 
SPH.e 
Mean 














63 6 ·r ~' 
65 6 ~:) 
6:1. C" ._.. ~J-.} 
/1 68 
11 CV(r) 6,2/. 
18 CV(R) 10r0/. 







5 C'J( r) 3r07. 
13 CV (R) 7,3% 
List of partleipants 
Lab. 
no. 
1. Ir K. Vandamme , 




2. Dr K.H. Palmork, 
Institute of Marine research, 
P.O. Box 1870- N 5011 Nordnes 
Bergen 
Norway 
3. Drs N.A.T. Kerkhoff, 
Rijksinstituut voor Visserijonderzoek, 
Postbus 68, 
1970 AB IJMUIDEN 
The Netherlands 
4. DrA. Montiel, 
Service de Controle des Eaux, 
Paris, 
144 Av P. Vaillant Couturier, 
75014 PARIS 
Fr a nee 
5. Dr A. Abarnou, 
Institut Scientifique et Technique des 
Pêches Haritimes 
Rue de l'Ile d'Jeu, 
PB 1049, 
44037 Nantes Cedex 
France. 
6. Dr H. earl 
Milchwirtschaftliche Untersuchungs- und 
Versuchsanstalt 
Hirnbeinstr. 10, 
D-8960 Kempten Allgäu 
Germany. 
7. Dr D.E. Wells 
Department of Agriculture and Fisherfes 
for Scotlancl, 
Fresh\-later Fisherfes Lab. 
Faskally Pitlochry Perthshire Ph 16 5 LB 
Scotland. 
8. Dr J .H. Petersen, 
tHuistry of the Environment 
National Food Institute 





9. Prof. U.A.Th. Brinkman, 
Free University 
Dept Analyt . Chemistry, 
De Boelelaan 1083, 
1081 HV ANSTERDAH . 
The Netherlands 
10. Ir L.G.M.Th. Tuinstra , 
State Institute for Quality Control of 
Agricultural Products, 
Bornsesteeg 45, 
6708 PD HAGENINGEN 
The Netherlands 
11. Dr L. Reutergärdh, 
Natl. Swedish Environment Prot. Board, 
Special Analytical Laboratory, 
University of Stockholm, 
Hallenberg Laboratory, 
S 106 91 Stockholm 
S~·7eden 
12. Prof. A. Liberti , 
Instituto Inquinamento Atmosferico CNR, 
Area della Ricerca di Roma, 
Via Salaria Km 29 . 300 - C. P. 10 
00016 Monterotondo Stazione (Roma) , 
Italy. 
13. Prof. K. Ballschmitte r 
Universität Ulm, 




14. Dr M. O'Sullivan, 
Dept of Fisheries, 
Fisherles Res . Centre, 
Abbotstown Castlenock Co Dublin 
Ireland. 
15. Dr E. Schulte 







State Institute for Quality Control of 
Agricultural Products 
ir L.G.M.Th. Tuinstra 
Bornsesteeg 45, 
6708 PD HAGENINGEN 
The Netherlands 
BCR-ringtests of individual chlorobiphenyls (2 /1983) 
Receipt/Confirmation letter 
I deelare herewith the receipt of a set ampuls for the BCR ring test. 
The ampuls have been received in good condition , yes/no. 
Damaged: ampul no ••••••.• , •••• • ••• , 
Loss of ,.,eight: ampul no • •••••••• , ••••••••• , •• , • , •••• 
I request for new ampuls cocled ,.,ith letter ••••• , ••••• , •••• •• 
Date: Signature: 





Results determination of minimum closing time of the splitter for 
PCB-compound 153 (4.2.1) 
Closing time of Response PCB 153 
the splitter (min) peak height (mm) peak \<lid th (mm) area (mmZ) 







Date of analysis: 
8427.24 
Annex 4 
BCR- ringtest (2/1983) 
Splitless injection 
Results determination of the optimum initial oven temperature (4 . 2 . 2) 
Initial temp(°C) Resolution Ratio peak height / peak area Peak symmetry 






Results determination of the optimum injector t emperature (4.2 . 3) 
Inlet temp( °C) Resolution Ratio peak heieht / peak area Peak symmetry 







Date of analysis: 
8427.25 
Annex 5 
BCR-ringtest (2 - 1983) 
Splitless injection 
Gaschromatographic conditions Laboratory: •••••••••• • •• • • • • •• 
Apparatus (type) 
EG- de tector (type) 
......... .......... .. 
..................... 
Column glass/fused silica * 
phasc 
length (m) .. .... .... .. ......... 
inner diameter (mm) 
film thickness (~m) 
..... .... .. .. .. 
Temperature (°C) 
column temp. programme 
chemical bonded yes/no * 
min , ,,,, .°C- l0°C/min- 220°C 
injector 
detector 
Inj ec tion volume 
••• • •••• • 0 c 
••••• • ••• 0 c 
.!__Hl. 
Splitless injection closing time splitter 
split ratio 
cm/sec Linear gas velocity 
type of gas nitrogen/helium/hydrogen *) 
Record er range • . ••• , • • mV 
chart speed , ,, ,,,, ,, cm/min 
*) Delete as necessary . 




On- column injection (optional) 
Results determination of the optimum initia! oven temperature (4.3 . 1) 
Initia! t emp( °C) Resolution Ratio peak height/peak area Peak symmetry 






Results determination of the optimum starting time for temperature 
programming (4 . 3 . 2) 
Starting time Resolution Ratio peak height / peak area Peak symmetry 






Labora t ory : 
Date of analysis : 
8427 . 27 
BCR-ringtest (2/1983) 
On-column injection (optional) 
Gaschromatographic conditions 
Apparatus (type) 
EG- detector (type) 
Column glass/fused silica * 
phase 
leneth (m) 
inner diameter (mm) 
film thickness (~m) 
Temperature (°C) 
column t emp . programme 
Annex 7 
Laboratory: ••••••••••••••••••• 
chemica! bonded yes/no * 
min •••••• oe- l0°C/min - 220°C 
injector ••••••• •• oe 
detector •• ••••••• °C 
Injection volume ..!:.....H_!._ . 
Linear gas velocity ••••••••••• cm/sec 
type of gas nitrogen/helium/hydrogen *) 
Recorder range •••••••• mV 
chart speed • • •• •• •• • cm/min 
Specify also specific conditions , for cooling time. 
*) Delete as necessary . 
842 7. 28 
Annex 8 
BCR- ringtest (2/1983) 
Results linearity test ( 4. 4) 
a . Splitless injection 
Hass injected (pg) Peak reight (mn) Peak \o!ldth (mn) Peak area ( mn2) Ratio 
at buf height peak area/mass 











b. On-col umt-injection ( optional) 
~áss injected (pg) Peak leight (mn) Peak 1-ll.dth (mn) Peak area (nru2) Ratio 
at bllf reight peak area/mass 










Laboratory: Dat e of analysis : 
*) Delete as neces sary 
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Annex 9 
BCR- ringtes t (2/1983) 
Re sults interlaboratory trial sample E 
a) calculated wit h internal standard TCN 









b) calculated with internal standard HBB 









All results are reported i n ~g/ml 
Labora tory : 
Date of ana1ysis : spl itless i njection 
on-column injection (optiona l) 
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Appendix 
Summary results laboratory 15. BCR ringtest 2/1983 
The results were received after we had finished the statistica! analy-
sis. Therefore all the results are reported separately in this appendix. 
For splitleas i njection 4 results and for on-column inj ec tion 3 
results were reported. 
1, Gaschromatographic conditions, splitless injection: 
Varian 3700, EC detector Ni63, 
Capillary column 50 m SE- 30/SE-54 (1:1), id 0,28 rum, film thickness 
0,07 ).lffio 
Temp. programme 4 min 90°C- 10°C/min- 220°C, 
Injector 240°C (tested range 180-240°C). 
Closing time of the splitter 120 sec (tested range 12- 180 sec) . 
Linear gas velocity (nitrogen) 24 cm/sec . 
2. Gaschromatographic conditlans on-column injection: 
Apparatus, detector, capillary column, linear gas veloei ty, see 
splitleas injection. 
Temp. progt·amme 0 min 80°C-10°C/min-220°C. 
3. Results 
a) Results splitless injection (ng/ml) 
PCB Internal standard TCN Internal standard HBB 
28 42 42 44 45 44 4ll '•7 44 
52 6'• 64 67 71 66 67 72 72 
101 81 78 80 81 84 82 86 84 
118 93 97 92 100 96 101 99 99 
153 88 88 87 96 91 91 94 94 
138 4LI 43 41 52 46 45 44 51 
180 63 62 59 66 64 65 64 65 
b) Results on-column injection (ng/ml) 
PCB Internal standard TCN Inte rnal standarcl HBB 
28 44 l,3 44 42 43 43 
52 73 64 68 71 64 66 
101 89 81~ 85 86 84 82 
118 105 101 102 101 101 98 
153 89 87 90 86 87 86 
138 43 43 45 42 46 44 
180 62 59 62 60 60 60 
Conclusion 
The se re sul ts l.,ere not used in the statistica! analysis. At fi rst 
sight most r esults are in good agreement with the reported results. 
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